Maurice Rapport

Maurice Rapport
Name	Maurice Rapport
Birth date	1919-02-28
Birth place	New York City
Death date	2011-04-06
Death place	Delray Beach, Florida
Nationality	American
Fields	Biochemistry, Neuroscience, Pharmacology
Alma mater	City College of New York, Columbia University
Known for	Isolation of serotonin
Awards	American Chemical Society awards, National Academies recognitions

Maurice Rapport (1919–2011) was an American biochemist and neuroscientist best known for his isolation and structural characterization of serotonin, a monoamine neurotransmitter. His work bridged organic chemistry, pharmacology, and neurobiology, influencing research in psychiatric medicine, cardiovascular physiology, and biochemistry laboratories worldwide. Rapport collaborated with researchers across institutions and his discoveries underpin therapies in psychiatry, cardiology, and neurology.

Early life and education

Rapport was born in New York City and attended Bronx High School of Science before matriculating at City College of New York where he studied chemistry and biology alongside contemporaries who later worked at Rockefeller University and Columbia University. He pursued graduate studies at Columbia University under mentors connected to the fields of organic synthesis and enzymology, interacting with faculty affiliated with Johns Hopkins University and Harvard Medical School. Rapport’s training included exposure to techniques developed at laboratories such as Max Planck Society-associated institutes and methods popularized by researchers from Massachusetts Institute of Technology and University of Chicago.

Research and major discoveries

Rapport’s seminal achievement was the purification and identification of the indoleamine later named serotonin, a molecule central to signaling in central nervous system and peripheral tissues. Working in a period influenced by scientists from Rockefeller Institute and contemporaneous with investigators at Kaiser Wilhelm Institute and Pasteur Institute, he isolated serotonin from blood serum and determined its basic indole structure using techniques comparable to those in University of Oxford and University of Cambridge laboratories. His characterization of the molecule informed subsequent work by teams at Eli Lilly and Company and Pfizer that led to pharmacological agents acting on serotonergic pathways, intersecting with studies from National Institutes of Health and World Health Organization research programs.

Rapport’s publications stimulated research on serotonin receptors, reuptake mechanisms, and metabolism studied by groups at Yale University, Stanford University, University of California, San Francisco, and University of Pennsylvania. These lines of research contributed to the development of selective serotonin reuptake inhibitors examined in clinical trials at Mayo Clinic and therapeutic guidelines shaped by panels from American Psychiatric Association and British Medical Association. His biochemical insights were integrated into investigations of platelet function pursued at Mount Sinai Hospital and vascular studies at Johns Hopkins Hospital.

Career and positions

Rapport held laboratory positions at institutions associated with pioneering biomedical research, collaborating with scientists from New York University, Columbia-Presbyterian Medical Center, and research centers influenced by the culture of Bell Labs-era innovation. He worked alongside investigators funded by National Science Foundation grants and partnered with colleagues from Weill Cornell Medicine and Roswell Park Comprehensive Cancer Center. His appointments included roles in academic departments connected to SUNY Downstate Medical Center and consulting stints with industrial research groups at companies such as Merck and GlaxoSmithKline where discoveries translated into drug discovery programs.

Throughout his career Rapport engaged with professional societies including the American Chemical Society, American Society for Pharmacology and Experimental Therapeutics, and international bodies like the International Brain Research Organization, contributing lectures at venues such as Cold Spring Harbor Laboratory and symposia at Society for Neuroscience meetings.

Awards and honors

Rapport received recognition from professional organizations and institutions that honor contributions to chemistry and medical research. He was acknowledged by the American Chemical Society and received citations in contexts associated with the National Academy of Sciences and regional academy awards. His work was celebrated at conferences organized by the Royal Society of Chemistry and lauded in retrospectives by departments at Columbia University and City College of New York. Later commemorations included symposiums at Cold Spring Harbor Laboratory and historical overviews published by editorial boards of journals affiliated with Oxford University Press and Elsevier.

Personal life and legacy

Rapport’s personal connections linked him to scientific communities in New York City and, later, to retirement communities in Florida where he remained engaged with colleagues from Columbia University and attendees of Society for Neuroscience reunions. His legacy persists in textbooks used at Harvard Medical School, Stanford School of Medicine, and University of Cambridge, and in the research programs at institutions such as Massachusetts General Hospital and Karolinska Institutet. Museums and archives at American Museum of Natural History and university special collections preserve correspondence and notebooks documenting collaborations with contemporaries from Rockefeller University and Yale School of Medicine. Students and mentees went on to lead laboratories at University of California, Berkeley, Imperial College London, and ETH Zurich, continuing work on serotonergic systems and informing therapies endorsed by agencies like Food and Drug Administration and advisory panels of the European Medicines Agency.

Category:American biochemists Category:Neuroscientists